SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 132.52 |
Enterprise Value ($M) | 55.50 |
Book Value ($M) | 170.68 |
Book Value / Share | 5.62 |
Price / Book | 0.78 |
NCAV ($M) | 153.10 |
NCAV / Share | 5.04 |
Price / NCAV | 0.87 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.22 |
Return on Assets (ROA) | -0.36 |
Return on Equity (ROE) | -0.38 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 38.41 |
Current Ratio | 38.41 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 157.19 |
Assets | 174.78 |
Liabilities | 4.09 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Point72 Asset Management, L.P. | 8.00 | 53.05 | |
13G/A | Baker Bros. Advisors Lp | 4.99 | 5.63 | |
13G/A | Hillhouse Capital Management, Ltd. | 2.40 | -50.00 | |
13G | Blue Owl Capital Holdings LP | 5.46 | ||
13G/A | Fmr Llc | 2.44 | -61.38 | |
13G | Kpcb Pandemic & Bio Defense Fund Llc | 6.30 | ||
13G | New Enterprise Associates 13 Lp | 6.60 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
80,633 | 493,879 | 16.33 | |
89,697 | 571,931 | 15.68 | |
148,179 | 817,055 | 18.14 | |
208,943 | 1,256,130 | 16.63 | |
(click for more detail) |
Similar Companies | |
---|---|
RYTM – Rhythm Pharmaceuticals, Inc. | SAGE – Sage Therapeutics, Inc. |
SCYX – SCYNEXIS, Inc. | SIGA – SIGA Technologies, Inc. |
SKYE – Skye Bioscience, Inc. |
Financial data and stock pages provided by
Fintel.io